Vollins James's Form 4 filing
Biodelivery Sciences International Inc (BDSI) · filed Feb 8, 2022
- Accession no.
- 0001103021-22-000029
- Filed
- Feb 8, 2022
- Trade date
- Feb 4, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $66.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vollins JamesCIK 0001757833 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2022 | Common Stock | SSaleDisposed | −18,541 | $3.60 | −$66,747.6 | 9,872 | Direct | |
| Feb 4, 2022 | Common Stock | FTax withholdingDisposed | −9,872 | $3.66 | −$36,131.52 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
General Counsel, Chief Compliance Officer & Corporate Secretary